In the last trading session, 1.37 million shares of the Compass Pathways Plc ADR (NASDAQ:CMPS) were traded, and its beta was 2.12. Most recently the company’s share price was $3.26, and it changed around -$0.12 or -3.55% from the last close, which brings the market valuation of the company to $302.69M. CMPS currently trades at a discount to its 52-week high of $8.54, offering almost -161.96% off that amount. The share price’s 52-week low was $2.25, which indicates that the current value has risen by an impressive 30.98% since then. We note from Compass Pathways Plc ADR’s average daily trading volume that its 10-day average is 7.93 million shares, with the 3-month average coming to 2.30 million.
Compass Pathways Plc ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.22. If we narrow it down even further, the data shows that 0 out of 10 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 1 recommended CMPS as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight.
Compass Pathways Plc ADR (NASDAQ:CMPS) trade information
Instantly CMPS has showed a red trend with a performance of -3.55% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 3.50 on recent trading dayincreased the stock’s daily price by 6.86%. The company’s shares are currently down -45.21% year-to-date, but still up 22.56% over the last five days. On the other hand, Compass Pathways Plc ADR (NASDAQ:CMPS) is -28.98% down in the 30-day period. We can see from the shorts that 5.29 million shares have been sold at a short interest cover period of 3.58 day(s).
The consensus price target as assigned by Wall Street analysts is $23, which translates to bulls needing to increase their stock price by 85.83% from its current value. Analyst projections state that CMPS is forecast to be at a low of $23 and a high of $23.
Compass Pathways Plc ADR earnings are expected to increase by 32.95% in 2025, but the outlook is positive 16.96% per year for the next five years.
CMPS Dividends
Compass Pathways Plc ADR’s next quarterly earnings report is expected to be released on 2025-May-08.
Compass Pathways Plc ADR (NASDAQ:CMPS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 13.64% of Compass Pathways Plc ADR shares, and 56.03% of them are in the hands of institutional investors. The stock currently has a share float of 64.88%. Compass Pathways Plc ADR stock is held by 163.0 institutions, with TCG CROSSOVER MANAGEMENT, LLC being the largest institutional investor. By 2024-06-30, it held 5.6427% of the shares, which is about 3.86 million shares worth $23.3 million.
CITADEL ADVISORS LLC, with 5.3652% or 3.67 million shares worth $22.16 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
ARK ETF Trust-ARK Genomic Revolution ETF and iShares Trust-iShares Biotechnology ETF were the top two Mutual Funds as of May 31, 2025 . The former held 1.59 shares worth $5.17 million, making up 1.70% of all outstanding shares. On the other hand, iShares Trust-iShares Biotechnology ETF held roughly 365.98 shares worth around $1.19 million, which represents about 0.39% of the total shares outstanding.
